← Company library
United States / Company briefSources checked 2026-10-04

Eli Lilly and Company

Develops medicines for diabetes, obesity, neuroscience, immune disorders and cancer, and is expanding US API manufacturing.

Foundayo / orforglipron

Approved

The release describes an oral small-molecule GLP-1 medicine approved in the US for weight management in adults with obesity, or overweight with a weight-related condition.

Completion reported

Broke ground on a USD 6.5 billion Houston API site. Production including Foundayo and over 600 jobs are plans, not evidence of completed operations.

Official role guide

Technology at Lilly

Not an individual vacancy

Observed 2026-10-04

Work
Lists AI, data engineering/science, MES engineering and software engineering as technology role areas.
Experience & requirements
Unconfirmed — The general page does not specify individual-role degrees, experience duration or required skill levels.

Information from a role guide does not establish a current vacancy.

Individual vacancy

Associate Director — Manufacturing Operations (Small Molecule)

Closed posting

Observed 2026-10-04

Work
Unconfirmed — The current original has been replaced by a closed notice, so detailed duties cannot be verified.
Experience & requirements
Unconfirmed — Detailed eligibility is not available in the current original.
Sources & coverage 3

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. Lilly Houston manufacturing groundbreaking ↗Eli Lilly and Company · Published 2026-09-21 · Sources checked 2026-10-03
  2. Technology at Lilly ↗Eli Lilly and Company · Published Date unconfirmed · Sources checked 2026-10-04
  3. Associate Director — Manufacturing Operations (Small Molecule) ↗Eli Lilly and Company · Published Date unconfirmed · Sources checked 2026-10-03